Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology
Disease Category: Hypogonadism
Trial Information
Effect of 7 Days of Exogenous Pulsatile GnRH Treatment on the Pituitary-Gonadal Axis in Hypogonadotropic Hypogonadal Subjects
Men with idiopathic hypogonadotropic hypogonadism (IHH) and Kallmann syndrome (KS) have a defect in Gonadotropin Releasing Hormone (GnRH). The purpose of the research study is to replace GnRH and examine the response of the pituitary (a gland in the brain) to the treatment. The information learned from this study will help us to better understand the response to treatment as well as to define subsets of IHH.
In this study, men age 18-65 with IHH/KS have a detailed evaluation which involves an overnight stay at the hospital and outpatient visits for one week.
Eligibility Criteria: Men 18-65 years diagnosed with IHH or KS
Andrew Dwyer, RN, MSN
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone: 617-726-8622
EMail: Adwyer@partners.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
